IC

Ikarian Capital Portfolio holdings

AUM $494M
1-Year Est. Return 153.64%
This Quarter Est. Return
1 Year Est. Return
+153.64%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$494M
AUM Growth
+$192M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
157
New
Increased
Reduced
Closed

Top Buys

1 +$53M
2 +$33.4M
3 +$27.2M
4
PTCT icon
PTC Therapeutics
PTCT
+$17.2M
5
RAPT icon
RAPT Therapeutics
RAPT
+$15.9M

Top Sells

1 +$21.6M
2 +$18.5M
3 +$17.9M
4
COGT icon
Cogent Biosciences
COGT
+$14.7M
5
VRNA
Verona Pharma
VRNA
+$13.9M

Sector Composition

1 Healthcare 99.25%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AGIO icon
26
Agios Pharmaceuticals
AGIO
$1.6B
$5.1M 0.51%
+126,979
DCTH icon
27
Delcath Systems
DCTH
$356M
$4.64M 0.47%
431,251
+108,861
GPCR icon
28
Structure Therapeutics
GPCR
$1.99B
$4.57M 0.46%
163,237
-19,848
TVTX icon
29
Travere Therapeutics
TVTX
$3.17B
$4.56M 0.46%
+190,781
FBRX icon
30
Forte Biosciences
FBRX
$250M
$4.5M 0.45%
300,000
-176,443
TARS icon
31
Tarsus Pharmaceuticals
TARS
$3.48B
$4.38M 0.44%
73,619
-122,917
KRYS icon
32
Krystal Biotech
KRYS
$6.43B
$4.31M 0.44%
+24,421
ARGX icon
33
argenx
ARGX
$56.4B
$4.3M 0.43%
+5,942
VTYX icon
34
Ventyx Biosciences
VTYX
$570M
$4.07M 0.41%
1,309,604
+342,014
PVLA
35
Palvella Therapeutics
PVLA
$1.11B
$4.06M 0.41%
+64,746
SLNO icon
36
Soleno Therapeutics
SLNO
$2.83B
$3.78M 0.38%
+55,946
LXEO icon
37
Lexeo Therapeutics
LXEO
$661M
$3.77M 0.38%
567,601
+17,572
LABD icon
38
Direxion Daily S&P Biotech Bear 3X Shares
LABD
$71.5M
$3.72M 0.38%
+91,959
RLMD icon
39
Relmada Therapeutics
RLMD
$290M
$3.7M 0.37%
1,843,060
+1,802,790
QURE icon
40
uniQure
QURE
$1.44B
$3.42M 0.35%
58,610
-61,376
VIR icon
41
Vir Biotechnology
VIR
$956M
$3.39M 0.34%
593,374
-474,688
MLTX icon
42
MoonLake Immunotherapeutics
MLTX
$1.07B
$3.12M 0.32%
+435,839
NAMS icon
43
NewAmsterdam Pharma
NAMS
$4.08B
$3.04M 0.31%
106,800
-100,000
UPB
44
Upstream Bio Inc
UPB
$1.52B
$3.03M 0.31%
+161,113
GUTS icon
45
Fractyl Health
GUTS
$273M
$2.86M 0.29%
+1,800,000
BBOT
46
BridgeBio Oncology
BBOT
$916M
$2.84M 0.29%
+245,231
BBIO icon
47
BridgeBio Pharma
BBIO
$14.4B
$2.7M 0.27%
+51,967
PEPG icon
48
PepGen
PEPG
$366M
$2.48M 0.25%
535,967
+385,967
STIM icon
49
Neuronetics
STIM
$101M
$2.47M 0.25%
905,716
-193,984
RLAY icon
50
Relay Therapeutics
RLAY
$1.39B
$2.44M 0.25%
467,362
-275,946